Relapsed/Refractory B-Cell LymphomaPhase 1/2NCT03223610Papers
ViPOR Combination
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation
What the film says
A stem cell transplant is the last big move against acute myeloid leukemia. When the leukemia returns afterward, the usual answer is more of the donor's immune cells, and it rarely works.
The idea: send trained soldiers, not more of them.
Natural killer cells are the immune system's first responders. Taken from the transplant donor and bathed overnight in three signaling molecules, they gain something like memory: more alert, and they stay that way.
In the first six patients, the cells multiplied ten to fifty-fold inside the body and persisted for months; fever and low blood counts were the main side effects.
Dana-Farber and Boston Children's, with Susanne Baumeister and Roman Shapiro, now test them from age twelve up. Public record; not medical advice.
Sources behind this film
Shapiro RM. J Clin Invest, 2022
Post-transplant relapse; donor lymphocyte infusion responses are typically poor; NK cells pre-activated overnight with IL-12, IL-15, IL-18 become "memory-like"; First six patients: 10- to 50-fold in vivo expansion sustained over months; fever and pancytopenia most common adverse events; Donor-derived cells after lymphodepletion, followed by IL-2
Romee R. Sci Transl Med, 2016
NK cells pre-activated overnight with IL-12, IL-15, IL-18 become "memory-like"
Donor-derived cells after lymphodepletion, followed by IL-2; Adults and children from age 12; Dana-Farber and Boston Children's; Baumeister and Shapiro
The drug
CIML NK cells have enhanced ability to recognize and kill leukemia targets
Cyclophosphamide (CP), also known as cytophosphane among other names, is a chemotherapy agent
This research study is a Phase I clinical trial, which tests the safety of an investigational intervention and also tries to define the appropriate dose of the investigational intervention to use for further studies. "Investigational" means that the intervention is being studied. The U.S. Food and Drug Administration (FDA) has not approved CIML NK Cell Infusion as a treatment for relapsed disease.
The study
This research study is studying cytokine induced memory-like natural killer (CIML NK) cells combined with IL-2 in adult patients (18 years of age or older) with Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) and Myeloproliferative Neoplasms (MPN) who relapse after haploidentical hematopoietic cell transplantation (haplo-HCT) or HLA matched stem cells.
This study will also study CIML NK cell infusion combined with IL-2 in pediatric patients (12 years of age or older) with AML, MDS, JMML who relapse after stem cell transplantation using HLA-matched related donor or related donor haploidentical stem cells.
Eligibility
Inclusion criteria as written on the registry, trimmed. The full list, with exclusions, is on the live record.
For you, or someone you love
A complex diagnosis brings new questions every week, in a trial and out of one. Triangle keeps your whole medical file together, reads it with you in plain language, and helps you and your family decide what to ask next.
Then $9 a month. Cancel anytime.
Requested from your hospitals and clinics through the national networks. Add scans, pathology and anything on paper.
Reports explained as they come in, with lab values you can follow before treatment, during a trial and after.
Ask about your own file, and walk in with questions for your oncologist or the trial team.
Share one profile with the family helping you, and with your doctors.
Members also get a deeper analysis of their records and any sequencing data, including clinical trials that may fit, reviewed by a licensed physician before they receive it.
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.
How these trials work: what Phase 1 actually is · common questions Not clinical evidence.